Tariro Makadzange is a Director in Biology at Gilead Sciences. She earned a BA at Smith College, an MD at Harvard Medical School and a Ph.D. (DPhil) at Oxford University. She trained in Internal Medicine at the University of Washington and completed a fellowship in Infectious Diseases at Massachusetts General Hospital where she later joined the faculty. Her research has focused on HIV immunology, clinical trials and implementation science. She has been engaged in training and mentoring HIV clinicians and researchers and co-established one of the largest HIV treatment programs in Zimbabwe. She currently leads a program focused on the development of a therapeutic HIV vaccine.
Where PSI will be at GHTechX
When we lead with consumer priorities, we can develop and scale health solutions that are relevant to consumers’ lives. But too often, we build health